Article Details

AI drug discovery platform Insilico Medicine announces $255 million in Series C funding

Retrieved on: 2021-06-22 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

AI drug discovery platform Insilico Medicine announces $255 million in Series C funding. View article details on hiswai:

Excerpt

... Development Corporation, Sequoia Capital China and Sage Partners. This current round was oversubscribed four-fold, according to Zhavoronkov.

Article found on: techcrunch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up